tiprankstipranks
Trending News
More News >
Immuneering (IMRX)
NASDAQ:IMRX
US Market
Advertisement

Immuneering (IMRX) Financial Statements

Compare
468 Followers

Immuneering Financial Overview

Immuneering's market cap is currently $362.91M. The company's EPS TTM is $-0.4; its P/E ratio is ―; Immuneering is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Immuneering Earnings and Revenue History

Immuneering Debt to Assets

Immuneering Cash Flow

Immuneering Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis